| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 84443 |
Thyroid stimulating hormone (TSH) |
2,134 |
1,767 |
$21K |
| 80053 |
Comprehensive metabolic panel |
2,562 |
2,048 |
$15K |
| 80061 |
Lipid panel |
1,847 |
1,544 |
$15K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
348 |
313 |
$15K |
| 36415 |
Collection of venous blood by venipuncture |
4,242 |
3,262 |
$14K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,504 |
1,945 |
$10K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
200 |
121 |
$9K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
237 |
210 |
$9K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
836 |
685 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
194 |
161 |
$3K |
| 87088 |
|
561 |
472 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
85 |
79 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
85 |
79 |
$2K |
| 84439 |
|
290 |
269 |
$2K |
| 82607 |
|
136 |
120 |
$1K |
| 87081 |
|
197 |
172 |
$801.96 |
| 85027 |
|
136 |
117 |
$583.13 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
40 |
37 |
$548.17 |
| 82728 |
|
30 |
24 |
$248.87 |
| 84153 |
|
12 |
12 |
$183.90 |
| 82043 |
|
28 |
25 |
$101.48 |
| 82570 |
|
17 |
15 |
$44.28 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
356 |
213 |
$0.00 |